Follow
Cherry Leung
Cherry Leung
BlueRock Therapeutics
No verified email
Title
Cited by
Cited by
Year
Self-renewal as a therapeutic target in human colorectal cancer
A Kreso, P Van Galen, NM Pedley, E Lima-Fernandes, C Frelin, T Davis, ...
Nature medicine 20 (1), 29-36, 2014
5462014
Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy
SK Rehman, J Haynes, E Collignon, KR Brown, Y Wang, AML Nixon, ...
Cell 184 (1), 226-242. e21, 2021
2962021
Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells
E Lima-Fernandes, A Murison, T da Silva Medina, Y Wang, A Ma, ...
Nature communications 10 (1), 1-14, 2019
392019
Administration of hypoxia-activated prodrug evofosfamide after conventional adjuvant therapy enhances therapeutic outcome and targets cancer-initiating cells in preclinical …
J Haynes, TD McKee, A Haller, Y Wang, C Leung, DMA Gendoo, ...
Clinical Cancer Research 24 (9), 2116-2127, 2018
222018
Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component
N Hussain, KR Thickett, H Na, C Leung, CS Tailor
Journal of virology 85 (23), 12529-12536, 2011
32011
Histone acetyltransferase 1 contributes to colon cancer initiating cell chemoresistance through DNA damage repair pathways
L Agro, C Leung, Y Wang, E Lima-Fernandes, C O'Brien
MOLECULAR CANCER RESEARCH 15, 2017
2017
Abstract B01: Histone acetyltransferase 1 contributes to colon cancer initiating cell chemoresistance through DNA damage repair pathways
L Agro, C Leung, Y Wang, E Lima-Fernandes, C O'Brien
Molecular Cancer Research 15 (4_Supplement), B01-B01, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–7